Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1142 of 5804
-
New study tests if asthma drug can stop symptoms Long-Term
Disease control Recruiting nowThis is an observational, multicenter, prospective study on patients with severe eosinophilic asthma treated with benralizumab aimed at evaluating the achievement of partial and complete clinical remission.
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New 30-Minute shock protocol could speed up emergency care
Disease control Not yet recruitingThis study aims to validate the effectiveness of the MINUTES bundle on clinical outcomes in patients presenting with undifferentiated shock.
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Zapping the brain while meditating in VR: a new anxiety fix?
Symptom relief ENROLLING_BY_INVITATIONThe goal of this RCT is to evaluate the post-intervention (week 2) and 1-month post-intervention (week 6) of a 2-week intervention (12 sessions) of combined tDCS (a non-invasive brain stimulation method, with anodal stimulation over lDLPFC and cathodal stimulation over rDLPFC) an…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Immune cell therapy takes on IBD: a new hope for tough cases?
Disease control Not yet recruitingThis is an open-label, Phase I, investigator-initiated trial (IIT) designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05 in patients with moderate-to-severe ulcerative colitis (UC) and Crohn's disease (CD). The enrolled populat…
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Robotic gloves and VR games aim to restore hand movement after stroke
Symptom relief Recruiting nowStroke is a common neurological disorder resulting from acute focal damage to the central nervous system due to vascular events such as cerebral infarction, intracerebral hemorrhage, or subarachnoid hemorrhage. It represents one of the leading causes of mortality and long-term di…
Phase: NA • Sponsor: Medipol University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New hope for tough lung cancer? experimental drug IBI363 targets resistant tumors
Disease control Not yet recruitingThis study is a prospective, single-arm, exploratory clinical trial designed to evaluate the efficacy and safety of IBI363 in patients with extensive-stage small cell lung cancer (ES-SCLC) who have progressed after at least two prior lines of standard therapy, including PD-1/PD-L…
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Your voice may reveal bipolar relapse before it strikes
Knowledge-focused Not yet recruitingBipolar disorder (BD) is a chronic, cyclical mental illness affecting over 1% of the global population. It is characterized by alternating episodes of elevated mood and energy (mania or hypomania) and episodes of decreased mood and energy (depression). Manic episodes involve hyp…
Phase: NA • Sponsor: Centre Hospitalier St Anne • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Single dose of ayahuasca or esketamine could ease PTSD symptoms
Symptom relief Recruiting nowDouble-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.
Phase: PHASE2 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could mixing HPV vaccines offer better protection?
Prevention OngoingThis study aims to assess the immunogenicity and safety of a sequential 2vhpv to 9vhpv immunization schedule in girls aged 9-14 years
Phase: PHASE4 • Sponsor: Zhejiang Provincial Center for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC
-
New drug GenSci143 enters first human tests for tough cancers
Disease control Recruiting nowA Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of GenSci143 in Participants with Advanced Solid Tumors
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blue dye gel shows promise for treating inoperable skin cancer
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to evaluate whether formulated methylene blue can safely and effectively treat advanced or inoperable Squamous Cell Carcinoma (SCC), a common type of skin cancer. This condition mainly affects adults and often occurs on the head or neck. Some pa…
Phase: PHASE3 • Sponsor: Daryoush Hamidi Alamdari, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Promising combo tackles tough lymphoma
Disease control Not yet recruitingThe objective of this study is to evaluate the efficacy and safety of golidocitinib in combination with the GemOx regimen in r/r PTCL
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo after stroke shows promise in preventing early decline
Disease control CompletedThis study (EPOCH-TECT) was a single-center, randomized, open-label, blinded, endpoint-assessing controlled trial conducted at the Affiliated Hospital of Xuzhou Medical University. It aimed to investigate the efficacy and safety of administering the PCSK9 inhibitor evolocumab ear…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
MRNA cancer therapy takes on blood tumors
Disease control Recruiting nowMalignant hematological tumors mainly derived from adult B cells are mainly acute lymphoblastic leukemia (ALL) and non Hodgkin lymphoma (NHL). Overall, although existing therapies have significantly improved the survival rates of most patients, the treatment of relapsed/refractor…
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Promising new imaging probes could spot prostate cancer missed by standard scans
Diagnosis Recruiting nowThe gastrin-releasing peptide receptor (GRPR) is highly expressed in prostate cancer (77%-100%). Numerous studies have confirmed that GRPR PET imaging has emerged as a significant molecular imaging modality in prostate cancer, particularly serving as a complementary tool to PSMA …
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New Stitch-Free staple technique aims to cut leak risk in rectal cancer surgery
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn whether a modified single-stapled anastomosis (MST) can reduce anastomotic leakage compared with the conventional double-stapled technique (DST) in adult patients undergoing laparoscopic or robotic low anterior resection for rectal canc…
Phase: NA • Sponsor: Korea University Anam Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood test may spot hidden cancer cells, guiding smarter treatment for esophageal cancer
Disease control ENROLLING_BY_INVITATIONNumerous studies have confirmed that ctDNA-MRD detection technology based on peripheral blood can identify minimal residual disease (MRD) following surgery and other curative treatments, indicating a higher risk of recurrence. Multiple exploratory studies in esophageal cancer hav…
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Dissolvable heart stent could replace metal ones in major trial
Disease control Recruiting nowBioresorbable scaffold (BRS) was designed aiming to avoid the late adverse events associated with permanent metallic stents by providing temporary support to the vessel wall and promoting vessel remodeling, plaque reduction, and restoring vasomotion after its full absorption. As …
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New study tests simple Nurse-Led plan to cut Post-Prostate surgery leaks
Symptom relief Recruiting nowUrinary incontinence is a common complication following radical prostatectomy and can significantly impact quality of life. Pelvic floor physiotherapy is recommended to reduce post-operative incontinence; however, referral pathways and patient engagement vary. The PRO-ACT trial …
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Blood tests may one day replace sleep studies for apnea
Knowledge-focused Recruiting nowObstructive sleep apnea (OSA) is a common sleep disorder associated with intermittent hypoxia, systemic inflammation, oxidative stress, and an increased risk of cardiovascular and metabolic diseases. Current diagnostic methods are effective but have limited availability and do no…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC